SIGIRR Mutation in Human Necrotizing Enterocolitis (NEC) Disrupts STAT3-Dependent microRNA Expression in Neonatal Gut

Wei Yu1, Inamul Haque1, Aparna Venkatraman1

  • 1Division of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri.

Abstract

Insights

A novel Single immunoglobulin interleukin-1-related receptor (SIGIRR) mutation disrupts immune tolerance in the neonatal gut, leading to necrotizing enterocolitis (NEC). This SIGIRR-STAT3-miRNA-IRAK1 pathway is crucial for postnatal intestinal adaptation.

Area of Science:

  • Immunology
  • Gastroenterology
  • Genetics

Background:

  • Single immunoglobulin interleukin-1-related receptor (SIGIRR) inhibits Toll-like receptor (TLR) signaling.
  • A novel SIGIRR stop mutation (p.Y168X) was identified in an infant with severe necrotizing enterocolitis (NEC).

Purpose of the Study:

  • Investigate mechanisms of SIGIRR mutations in neonatal gut TLR hyper-responsiveness.
  • Determine how SIGIRR mutations disrupt postnatal intestinal adaptation.

Main Methods:

  • Generated transgenic mice with the SIGIRR p.Y168X mutation using CRISPR/Cas9.
  • Assessed inflammation, STAT3 phosphorylation, miRNA, and IRAK1 expression in mouse and human intestinal cells.
  • Utilized Western blot, qRT-PCR, and luciferase assays to study SIGIRR-STAT3 signaling.

Main Results:

  • SigirrTg mice exhibited increased intestinal inflammation and NF-κB activation with decreased miR-146a/miR-155 expression.
  • The p.Y168X mutation impaired SIGIRR-mediated STAT3-dependent miRNA expression.
  • Decreased miR-146a led to increased IRAK1 expression, hindering gut adaptation.

Conclusions:

  • Uncovered a novel SIGIRR-STAT3-miRNA-IRAK1 repression pathway regulating postnatal intestinal adaptation.
  • SIGIRR mutations identified in NEC disrupt this pathway, causing loss of intestinal immune tolerance.
  • Provides insights into genetic mutations in SIGIRR contributing to NEC pathogenesis.